Latest filing published 24 May 2022 for Virios Therapeutics, Inc., €8,566.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Angela Walsh: trading record in brief
Angela Walsh, listed as senior executive, appears in our data through filings on Dogwood Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 28 January 2021 to 23 May 2022.
Every open-market trade on record is a purchase: 2 purchases worth €15k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2022, the count stands at 1 purchase and no sales.
Most recently, on 24 May 2022, the filings show an open-market purchase worth €8,566 in Dogwood Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Angela Walsh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$4.575100.0% of flowCommon StockSEC:0001415889-22-005575:0Canonical exit: 21 Aug 2022 (T+90)
1 of 1 declaration